P4–244: Discovery of a novel series of notch–sparing γ–secretase inhibitors
Boyd L. Harrison, Steven J. Jacobsen(Mayo Clinic), David Riddell(Eli Lilly (United States)), John W. Ellingboe(Pearl River Community College), Joseph R. Stock, Susan Aschmies(Princeton University), Charles W. Mann(Princeton University), Hua Zhou(Dalian Medical University), Mei Jin, Diane B. Hauze(Princeton University), Erik Wagner(Princeton University), Yun Hu(Princeton University), Kevin R. Woller, Kevin Atchison(Merck & Co., Inc., Rahway, NJ, USA (United States)), William Moore, Robert Martone(Princeton University), Anthony F. Kreft, Shaiu-Ching Sun, Donna M. Huryn, Dennis Kubrak, Zheng Xu(First Teaching Hospital of Tianjin University of Traditional Chinese Medicine), Peimin Lu, Alex Porte, June Sonnenberg‐Reines, Derek C. Cole
Cited by 0
Related Papers
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Proteogenomic Characterization of Endometrial Carcinoma
|Cell|2020|534
Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor
|Journal of Medicinal Chemistry|2012|460
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
|Journal of Neuroscience|2008|351